HER2-positive Bladder Cancer

Explore clinical trials studying HER2-positive Bladder Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HER2-positive Bladder Cancer trial results

Recruiting

NCT06253871

Conditions: Brain Diseases, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, +36 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

University of Miami Miami, Florida, United States

View all 53 locations

Completed

NCT03330561

Conditions: HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

University of California Los Angeles (UCLA) Santa Monica, California, United States

Georgetown University, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

Johns Hopkins University School of Medicine Baltimore, Maryland, United States

Completed

NCT03650348

Conditions: HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

UCLA Health Santa Monica, California, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States